Subtherapeutic Antibiotics and Productivity in U.S. Hog Production

William McBride, Nigel Key and Kenneth Mathews

Review of Agricultural Economics, 2008, vol. 30, issue 2, 270-288

Abstract: Antimicrobial drugs are fed to hogs at subtherapeutic levels to prevent disease and promote growth. However, there is concern that the presence of antimicrobial drugs in hog feed is a factor promoting the development of antimicrobial drug-resistant bacteria. This study uses a treatment-effects sample-selection model to examine the impact that feeding antibiotics has on the productivity of U.S. hog operations. No relationship was found between productivity and antibiotics fed during finishing, but productivity was significantly improved when antibiotics were fed to nursery pigs. Restrictions on feeding antimicrobial drugs during the nursery phase would likely impose significant economic costs on U.S. hog producers. Copyright 2008, Oxford University Press.

Date: 2008
References: Add references at CitEc
Citations: View citations in EconPapers (2)

Downloads: (external link)
http://hdl.handle.net/10.1111/j.1467-9353.2008.00404.x (application/pdf)
Access to full text is restricted to subscribers.

Related works:
Journal Article: Subtherapeutic Antibiotics and Productivity in U.S. Hog Production (2008)
Working Paper: Sub-therapeutic Antibiotics and Productivity in U.S. Hog Production (2006)
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:oup:revage:v:30:y:2008:i:2:p:270-288

Ordering information: This journal article can be ordered from
https://academic.oup.com/journals

Access Statistics for this article

More articles in Review of Agricultural Economics from Agricultural and Applied Economics Association Oxford University Press, Great Clarendon Street, Oxford OX2 6DP, UK. Contact information at EDIRC.
Bibliographic data for series maintained by Oxford University Press ( this e-mail address is bad, please contact ) and Christopher F. Baum ().